The art and science of dermal formulation development / (Record no. 72400)

000 -LEADER
fixed length control field 05964cam a2200637Ki 4500
001 - CONTROL NUMBER
control field 9780429059872
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220531132436.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190301s2019 flu ob 001 0 eng d
040 ## - Cataloging Source
-- OCoLC-P
-- eng
-- rda
-- pn
-- OCoLC-P
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429059872
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429059876
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429593482
-- (electronic bk. : Mobipocket)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429593481
-- (electronic bk. : Mobipocket)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429596063
-- (electronic bk. : PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429596065
-- (electronic bk. : PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429594779
-- (electronic bk. : EPUB)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429594771
-- (electronic bk. : EPUB)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781138064928
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 1138064920
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1088892375
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC-P)1088892375
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM151
Item number .B76 2019eb
072 #7 -
-- MED
-- 071000
-- bisacsh
072 #7 -
-- MED
-- 017000
-- bisacsh
072 #7 -
-- MED
-- 072000
-- bisacsh
072 #7 -
-- TDCW
-- bicssc
082 04 -
-- 615/.6
-- 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Brown, Marc D.,
Relator term author.
245 14 - TITLE STATEMENT
Title The art and science of dermal formulation development /
Statement of responsibility, etc. Marc Brown, Adrian C. Williams.
264 #1 -
-- Boca Raton, Florida :
-- CRC Press,
-- [2019]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
490 0# -
-- Drugs and the pharmaceutical sciences
505 0# -
-- Cover; Half Title; Series Page; Title Page; Copyright Page; Dedication; Contents; Preface; Acknowledgements; About the Authors; Chapter 1: Structure and Function of Human Skin; 1.1 Introduction; 1.2 Healthy Skin Structure and Function; 1.2.1 The Subcutaneous Fat Layer; 1.2.2 The Dermis; 1.2.2.1 Pilosebaceous Unit; 1.2.2.2 Eccrine (Sweat) Glands; 1.2.2.3 Apocrine Glands; 1.2.3 The Epidermis; 1.2.3.1 Basement Membrane; 1.2.3.2 The Stratum Basale (Stratum Germinativum or, More Commonly, Basal Layer); 1.2.3.3 The Stratum Spinosum (Spinous Layer/Prickle Cell Layer)
505 8# -
-- 1.2.3.4 The Stratum Granulosum (Granular Layer)1.2.3.5 The Stratum Lucidum; 1.2.3.6 The Stratum Corneum (Horny Layer); 1.2.4 Epidermal Enzyme Systems; 1.3 Physiological Factors Affecting Transdermal and Topical Drug Delivery; 1.3.1 Gender; 1.3.2 Skin Age; 1.3.3 Body Site; 1.3.4 Race; 1.3.5 Other Factors; 1.4 Skin Microbiome; 1.5 Damaged Skin; References; Chapter 2: Theoretical Aspects of Transdermal and Topical Drug Delivery; 2.1 Terminology; 2.2 The Transdermal Permeation Process; 2.3 Permeation Pathways through the Stratum Corneum; 2.3.1 Transappendageal Transport (Shunt Route Transport)
505 8# -
-- 2.3.2 Transcellular Route2.3.3 Intercellular Pathway; 2.4 Influence of Permeant Physicochemical Properties on Route of Absorption; 2.4.1 Partition Coefficient; 2.4.2 Molecular Size; 2.4.3 Solubility/Melting Point; 2.4.4 Ionisation; 2.4.5 Other Factors; 2.4.6 Biomacromolecules; 2.5 Mathematics of Skin Permeation; 2.5.1 Pseudo Steady-State Permeation (Infinite Dosing); 2.5.2 Concentration Gradient or Thermodynamic Activity?; 2.5.3 Transient Permeation (Finite Dosing); References; Chapter 3: Chemical Modulation of Topical and Transdermal Permeation; 3.1 Introduction
505 8# -
-- 3.2 Chemical Modulation of Drug Flux3.2.1 Mechanisms of Chemical Penetration Enhancement; 3.2.1.1 Interaction (Disordering) of Intercellular Lipids; 3.2.1.2 Interactions within Corneocytes; 3.2.1.3 Alteration of Partitioning; 3.2.1.4 Other Mechanisms of Chemical Penetration Enhancement; 3.2.2 Common Chemical Penetration Enhancers; 3.2.2.1 Water; 3.2.2.2 Sulphoxides and Similar Chemicals; 3.2.2.3 Pyrrolidones; 3.2.2.4 Azone; 3.2.2.5 Fatty Acids; 3.2.2.6 Alcohols, Fatty Alcohols, and Glycols; 3.2.2.7 Surfactants; 3.2.2.8 Urea; 3.2.2.9 Terpenes; 3.2.2.10 Phospholipids
505 8# -
-- 3.2.2.11 Amino Acid-Based Enhancers3.2.2.12 Peptides; 3.2.3 Synergy between Chemical Penetration Enhancers; 3.2.4 General Comments on Penetration Enhancers; 3.3 Permeation Retardation; 3.4 Drug and Formulation Manipulation Strategies; 3.4.1 Prodrugs; 3.4.2 Ion-Pairing; 3.4.3 Eutectic Systems/Depression of Permeant Melting Point; 3.4.4 Supersaturation; References; Chapter 4: Physical and Technological Modulation of Topical and Transdermal Drug Delivery; 4.1 Introduction; 4.2 Vesicles; 4.2.1 Liposomes; 4.2.2 Non-Ionic Surfactant Vesicles (Niosomes)
520 ## -
-- The Art and Science of Dermal Formulation Development is a comprehensive guide to the theory and practice of transdermal and topical formulation development, covering preclinical studies, evaluation, and regulatory approval. It enables the reader to understand the opportunities and challenges in developing products and how risks can be mitigated. Over the last 25 years, expertise in this area has declined whilst drug delivery systems for other administration routes have developed significantly. The advantages offered by transdermal and topical drug delivery remain compelling for sectors including the pharmaceutical industry, personal care, and cosmetics. This text addresses the dearth of expertise and discusses how skin can be a route of delivery and the processes in formulation development, but how such an application is very different to that used for oral, IV, and other administration routes.
588 ## -
-- OCLC-licensed vendor bibliographic record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Transdermal medication.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Transdermal medication
General subdivision Research
-- Methodology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Dermatologic agents
General subdivision Absorption and adsorption.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Skin
General subdivision Physiology.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Pharmacology
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Dermatology
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Pharmacy
Source of heading or term bisacsh
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Williams, A. C.
Fuller form of name (Adrian C.)
856 40 -
-- Taylor & Francis
-- https://www.taylorfrancis.com/books/9780429059872
856 42 -
-- OCLC metadata license agreement
-- http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf

No items available.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571